{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:16:27Z","timestamp":1789215387347,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.tiv.2021.105223","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T01:46:58Z","timestamp":1626745618000},"page":"105223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Application of in vitro data in physiologically-based kinetic models for quantitative in vitro-in vivo extrapolation: A case-study for baclofen"],"prefix":"10.1016","volume":"76","author":[{"given":"Emma E.J.","family":"Kasteel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie S.","family":"Lautz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Culot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nynke I.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Zwartsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tiv.2021.105223_bb0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0883073814535504","article-title":"A pilot study assessing pharmacokinetics and tolerability of oral and intravenous baclofen in healthy adult volunteers","volume":"30","author":"Agarwal","year":"2015","journal-title":"J. Child Neurol."},{"issue":"9","key":"10.1016\/j.tiv.2021.105223_bb0010","first-page":"497","article-title":"Increase of baclofen intoxications: risks involved and management","volume":"72","author":"Arbouw","year":"2014","journal-title":"Neth. J. Med."},{"issue":"1","key":"10.1016\/j.tiv.2021.105223_bb0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000542-200607000-00027","article-title":"Cerebrospinal fluid and spinal cord distribution of baclofen and bupivacaine during slow intrathecal infusion in pigs","volume":"105","author":"Bernards","year":"2006","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.tiv.2021.105223_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099733","article-title":"A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells","volume":"9","author":"Cecchelli","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.tiv.2021.105223_bb0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1542\/peds.2013-4060","article-title":"Off-label use of drugs in children","volume":"133","author":"Committee on Drugs","year":"2014","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.tiv.2021.105223_bb0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/brain\/91.4.707","article-title":"Formation and absorption of cerebrospinal fluid in man","volume":"91","author":"Cutler","year":"1968","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.tiv.2021.105223_bb0035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.tiv.2021.105223_bb0040","series-title":"Blood-Brain Barrier in Drug Discovery","first-page":"296","article-title":"PBPK modeling approach for predictions of human CNS drug brain distribution","author":"de Lange","year":"2015"},{"issue":"12","key":"10.1016\/j.tiv.2021.105223_bb0045","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1023\/A:1016263032765","article-title":"Study on brain interstitial fluid distribution and blood-brain barrier transport of baclofen in rats by microdialysis","volume":"12","author":"Deguchi","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2021.105223_bb0050","series-title":"Baclofen","author":"Drugbank","year":"2005"},{"key":"10.1016\/j.tiv.2021.105223_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cotox.2020.03.001","article-title":"Physiologically based pharmacokinetic modeling: a promising tool for translational research and regulatory toxicology","volume":"23-24","author":"Fairman","year":"2020","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.tiv.2021.105223_bb0060","series-title":"Lioresal Intrathecal: Baclofen Injection","author":"FDA","year":"2011"},{"key":"10.1016\/j.tiv.2021.105223_bb0065","series-title":"Gablofen (Baclofen Injection): Highlights of Prescribing Information","author":"FDA","year":"2015"},{"key":"10.1016\/j.tiv.2021.105223_bb0070","series-title":"OZOBAX (Baclofen) Oral Solution: highlights of Prescribing Information","author":"FDA","year":"2019"},{"key":"10.1016\/j.tiv.2021.105223_bb0075","author":"Fidler"},{"issue":"20","key":"10.1016\/j.tiv.2021.105223_bb0080","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1021\/jm901036q","article-title":"Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids","volume":"52","author":"Friden","year":"2009","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.tiv.2021.105223_bb0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.dmpk.2016.03.005","article-title":"Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: estimating time varying CSF drug concentrations and their variability using in vitro data","volume":"31","author":"Gaohua","year":"2016","journal-title":"Drug Metabol. Pharm."},{"issue":"Pt 3","key":"10.1016\/j.tiv.2021.105223_bb0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/000456328802500312","article-title":"Biological variation of serum and urine creatinine and creatinine clearance: ramifications for interpretation of results and patient care","volume":"25","author":"Gowans","year":"1988","journal-title":"Ann. Clin. Biochem."},{"issue":"1","key":"10.1016\/j.tiv.2021.105223_bb0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/bcp.12781","article-title":"A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticity","volume":"81","author":"Heetla","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tiv.2021.105223_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2016.04.020","article-title":"Neurotoxicity screening of (illicit) drugs using novel methods for analysis of microelectrode array (MEA) recordings","volume":"55","author":"Hondebrink","year":"2016","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.tiv.2021.105223_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2017.04.035","article-title":"Neuropharmacological characterization of the new psychoactive substance methoxetamine","volume":"123","author":"Hondebrink","year":"2017","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.tiv.2021.105223_bb0110","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/jps.23575","article-title":"Quantitative Atlas of blood–brain barrier transporters, receptors, and tight junction proteins in rats and common Marmoset","volume":"102","author":"Hoshi","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2021.105223_bb0115","author":"Iooss"},{"key":"10.1016\/j.tiv.2021.105223_bb0120","series-title":"Characterization and application of physiologically based pharmacokinetic models in risk assessment","author":"IPCS","year":"2010"},{"key":"10.1016\/j.tiv.2021.105223_bb0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.toxlet.2017.02.014","article-title":"Comparison of the acute inhibitory effects of Tetrodotoxin (TTX) in rat and human neuronal networks for risk assessment purposes","volume":"270","author":"Kasteel","year":"2017","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.tiv.2021.105223_bb0130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/clpt.1985.167","article-title":"The pharmacokinetics of baclofen derived from intestinal infusion","volume":"38","author":"Kochak","year":"1985","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2021.105223_bb0135","series-title":"Parenteral Drug Therapy in Spasticity and Parkinson\u2019s Disease","first-page":"67","article-title":"Cerebrospinal fluid pharmacokinetics of lumbar intrathecal baclofen","author":"Kroin","year":"1992"},{"issue":"1","key":"10.1016\/j.tiv.2021.105223_bb0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/toxsci\/kfx070","article-title":"Performance assessment and translation of physiologically based pharmacokinetic models from acslX to Berkeley madonna, MATLAB, and R language: oxytetracycline and gold nanoparticles as case examples","volume":"158","author":"Lin","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.tiv.2021.105223_bb0145","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.yrtph.2008.01.011","article-title":"Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps","volume":"50","author":"Loizou","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tiv.2021.105223_bb0150","author":"Mersmann"},{"issue":"2","key":"10.1016\/j.tiv.2021.105223_bb0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00001199-200403000-00003","article-title":"Orally delivered baclofen to control spastic hypertonia in acquired brain injury","volume":"19","author":"Meythaler","year":"2004","journal-title":"J. Head Trauma Rehabil."},{"issue":"5","key":"10.1016\/j.tiv.2021.105223_bb0160","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1208\/s12248-017-0110-8","article-title":"SLC and ABC transporters: expression, localization, and species differences at the blood-brain and the blood-cerebrospinal fluid barriers","volume":"19","author":"Morris","year":"2017","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.tiv.2021.105223_bb0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.tiv.2021.105223_bb0170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.comtox.2018.11.002","article-title":"Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making","volume":"9","author":"Paini","year":"2019","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.tiv.2021.105223_bb0175","first-page":"1","article-title":"Utilization of physiologically based pharmacokinetic modeling in clinical pharmacology and therapeutics: an overview","author":"Perry","year":"2020","journal-title":"Curr. Pharmacol. Rep."},{"issue":"7","key":"10.1016\/j.tiv.2021.105223_bb0180","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00204-019-02479-6","article-title":"Quantitative in vitro-to-in vivo extrapolation (QIVIVE) of estrogenic and anti-androgenic potencies of BPA and BADGE analogues","volume":"93","author":"Punt","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2021.105223_bb0185","author":"R Development Core Team"},{"issue":"6","key":"10.1016\/j.tiv.2021.105223_bb0190","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.20502","article-title":"Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions","volume":"95","author":"Rodgers","year":"2006","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.tiv.2021.105223_bb0195","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jps.20322","article-title":"Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases","volume":"94","author":"Rodgers","year":"2005","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.tiv.2021.105223_bb0200","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00265844","article-title":"CSF baclofen levels after intrathecal administration in severe spasticity","volume":"40","author":"Sallerin-Caute","year":"1991","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.tiv.2021.105223_bb0205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.reprotox.2017.06.043","article-title":"The great barrier belief: the blood\u2013brain barrier and considerations for juvenile toxicity studies","volume":"72","author":"Schmitt","year":"2017","journal-title":"Reprod. Toxicol."},{"issue":"8","key":"10.1016\/j.tiv.2021.105223_bb0210","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.pmrj.2016.11.002","article-title":"A randomized dose escalation study of intravenous baclofen in healthy volunteers: clinical tolerance and pharmacokinetics","volume":"9","author":"Schmitz","year":"2017","journal-title":"PM&R"},{"key":"10.1016\/j.tiv.2021.105223_bb0215","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.toxlet.2018.06.1217","article-title":"Development of a human physiologically based pharmacokinetic (PBPK) model for phthalate (DEHP) and its metabolites: a bottom up modeling approach","volume":"296","author":"Sharma","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tiv.2021.105223_bb0220","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3389\/fpsyt.2018.00485","article-title":"Pharmacokinetic studies of baclofen are not sufficient to establish an optimized dosage for management of alcohol disorder","volume":"9","author":"Simon","year":"2018","journal-title":"Front Psychiatry"},{"issue":"7","key":"10.1016\/j.tiv.2021.105223_bb0225","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.ress.2006.07.001","article-title":"Estimating the approximation error when fixing unessential factors in global sensitivity analysis","volume":"92","author":"Sobol","year":"2007","journal-title":"Reliab. Eng. Syst. Saf."},{"issue":"61","key":"10.1016\/j.tiv.2021.105223_bb0230","article-title":"Immune responses at brain barriers and implications for brain development and neurological function in later life","volume":"7","author":"Stolp","year":"2013","journal-title":"Front. Integr. Neurosci."},{"issue":"3","key":"10.1016\/j.tiv.2021.105223_bb0235","first-page":"261","article-title":"Is the time right for in vitro neurotoxicity testing using human iPSC-derived neurons?","volume":"33","author":"Tukker","year":"2016","journal-title":"ALTEX"},{"key":"10.1016\/j.tiv.2021.105223_bb0240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuro.2018.06.007","article-title":"Human iPSC-derived neuronal models for in vitro neurotoxicity assessment","volume":"67","author":"Tukker","year":"2018","journal-title":"NeuroToxicology"},{"issue":"4","key":"10.1016\/j.tiv.2021.105223_bb0245","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/156720211798121016","article-title":"Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes","volume":"8","author":"Vandenhaute","year":"2011","journal-title":"Curr. Neurovasc. Res."},{"issue":"6","key":"10.1016\/j.tiv.2021.105223_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007117","article-title":"Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis","volume":"15","author":"Verscheijden","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.tiv.2021.105223_bb0255","doi-asserted-by":"crossref","first-page":"107541","DOI":"10.1016\/j.pharmthera.2020.107541","article-title":"Physiologically-based pharmacokinetic models for children: Starting to reach maturation?","author":"Verscheijden","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.tiv.2021.105223_bb0260","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00431-012-1780-y","article-title":"Baclofen intoxication: a \u201cfun drug\u201d causing deep coma and nonconvulsive status epilepticus-a case report and review of the literature","volume":"171","author":"Wei\u00dfhaar","year":"2012","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.tiv.2021.105223_bb0265","author":"Wickham"},{"issue":"1","key":"10.1016\/j.tiv.2021.105223_bb0270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00007691-200302000-00014","article-title":"Pharmacokinetics of a single oral dose of baclofen in pediatric patients with gastroesophageal reflux disease","volume":"25","author":"Wiersma","year":"2003","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.tiv.2021.105223_bb0275","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejps.2017.11.011","article-title":"Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approach","volume":"112","author":"Yamamoto","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2021.105223_bb0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuro.2018.03.007","article-title":"Neurotoxicity screening of new psychoactive substances (NPS): effects on neuronal activity in rat cortical cultures using microelectrode arrays (MEA)","volume":"66","author":"Zwartsen","year":"2018","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.tiv.2021.105223_bb0285","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuro.2019.05.004","article-title":"Changes in neuronal activity in rat primary cortical cultures induced by illicit drugs and new psychoactive substances (NPS) following prolonged exposure and washout to mimic human exposure scenarios","volume":"74","author":"Zwartsen","year":"2019","journal-title":"NeuroToxicology"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723332100148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723332100148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:38:24Z","timestamp":1760135904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088723332100148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":57,"alternative-id":["S088723332100148X"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2021.105223","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of in vitro data in physiologically-based kinetic models for quantitative in vitro-in vivo extrapolation: A case-study for baclofen","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2021.105223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105223"}}